Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Παρόμοια τεκμήρια

• The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
  ανά: Patmanathan, S.N., κ.ά.
  Έκδοση: (2015)
• Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
  ανά: Anthony, D, κ.ά.
  Έκδοση: (2014)
• The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
  ανά: Stradner Martin H, κ.ά.
  Έκδοση: (2011-12-01)
• Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
  ανά: Siyao Li, κ.ά.
  Έκδοση: (2023-07-01)
• The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
  ανά: Masayo Aoki, κ.ά.
  Έκδοση: (2020-01-01)